核子醫學設備市場規模、佔有率和成長分析：按產品類型、應用、最終用戶和地區分類－2026-2033年產業預測

2024 年全球核醫設備市場價值為 26 億美元，預計到 2025 年將成長至 28 億美元，到 2033 年將成長至 50.3 億美元，在預測期（2026-2033 年）內複合年成長率為 7.6%。

由於分子影像和精準診斷的顯著發展，核醫設備市場正在擴張，這有助於早期檢測和標靶治療，並改善患者預後。這些設備包括伽馬攝影機、SPECT、PET、PET/CT 和 PET/MRI 混合掃描儀，以及迴旋加速器和循環系統製備工具，將放射性藥物科學轉化為可操作的臨床決策。這些技術的應用正在迅速成長，尤其是在腫瘤學和心臟病學領域。 PSMA-PET 正在顯著改變前列腺癌的治療管理，醫療機構正利用 PET 影像進行癌症分期。此外，放射性藥物生態系統的快速發展正在推動全球需求，穩定的同位素供應加速了掃描儀的普及。保險報銷率的提高，以及人工智慧和影像分析技術的進步，正促使醫院投資混合系統並擴展其服務，尤其是在新興市場。

全球核子醫學設備市場的成長要素

隨著癌症和心血管疾病發病率的不斷上升，全球對核子醫學領域創新診斷和治療方案的需求顯著成長。核子醫學能夠提供獨特的分子和功能訊息，有助於制定個人化的治療策略。醫療專業人員越來越依賴核子醫學掃描術診斷和放射性藥物療法進行疾病早期檢測、監測治療進展以及開展以患者為中心的干預措施，因此，醫院和影像中心被敦促增加對PET、SPECT和放射性核素治療等先進基礎設施的投資。這種臨床上的迫切需求正在推動整個醫療系統採購和研發最先進的設備，並重塑核子醫學的模式。

全球核子醫學設備市場的限制因素

全球核子醫學設備市場面臨許多限制因素，其中之一是採用和維護先進技術需要大量的資本投入。這些資金障礙不僅源自於初始購置成本，也源自於設施維修和專用設備的持續維護費用。這些營運上的複雜性，加上定期維護和放射性藥物資源的需求，進一步加重了財務負擔。因此，資源有限的小規模醫療機構和設施可能不願意投資，或選擇專注於其他診斷方法。由此可見，儘管臨床應用價值和市場需求都很高，但市場成長卻受到阻礙，導致創新技術的應用推廣落後。

全球核子醫學設備市場趨勢

全球核醫設備市場正呈現「診療整合」 （治療診斷學）的顯著融合與擴展趨勢，即將診斷影像與標靶放射性核種治療結合。在這種不斷變化的市場格局下，設備製造商必須在造影劑、檢測器和給藥系統的設計上進行創新，以支援診斷和治療的雙重工作流程。包括製造商、臨床中心和研究機構在內的主要相關人員，正優先考慮模組化設計和跨學科方案，以促進個人化治療計劃的發展。隨著協作生態系統的出現，對能夠促進以患者為中心的護理模式的靈活平台的需求日益成長，從而在統一的臨床環境中增強跨多個地點的臨床決策和運營協調。

目錄

介紹

• 調查目的
• 市場定義和範圍

調查方法

• 研究過程
• 二級資料和一級資料的方法
• 市場規模估算方法

執行摘要

• 全球市場展望
• 市場主要亮點
• 細分市場概覽
• 競爭環境概述

市場動態及展望

• 總體經濟指標
• 促進者和機會
• 抑制因素和挑戰
• 供給面趨勢
• 需求面趨勢
• 波特的分析和影響

關鍵市場分析

• 關鍵成功因素
• 影響市場的因素
• 主要投資機會
• 生態系測繪
• 2025年市場魅力指數
• PESTLE分析
• 監理情勢

全球核子醫學設備市場規模：依產品類型分類

• SPECT系統
  • 混合SPECT系統
  • 獨立式SPECT系統
• PET系統
• 平面閃爍顯像
• 其他

全球核子醫學設備市場規模：依應用領域分類

• 腫瘤學
• 循環系統
• 神經病學
• 其他

全球核子醫學設備市場規模：依最終用戶分類

• 醫院
• 診斷中心
• 研究機構

全球核子醫學設備市場規模：依地區分類

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太國家
• 拉丁美洲
  • 墨西哥
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲國家

競爭資訊

• 前五大公司對比
• 主要公司2025年的市場定位
• 主要市場公司採取的策略
• 近期市場趨勢
• 企業市場占有率分析，2025 年
• 主要公司的完整公司簡介
  • 公司詳情
  • 產品系列分析
  • 按細分市場進行企業市佔率分析
  • 銷售收入年比比較（2023-2025 年）

主要公司簡介

• Siemens Energy
• General Electric
• Philips
• Hitachi
• Canon
• Shimadzu Corporation
• Digirad
• Mediso Medical Imaging Systems
• Surgeons Choice Medical
• Lantheus Holdings
• Eckert & Ziegler
• Cardinal Health
• Bracco
• Fujifilm Holdings
• Spectrum Dynamics Medical
• CMR Naviscan
• Milaidhoo
• Segami Corporation
• MedEx
• Nuclisys

結論與建議

Global Nuclear Medicine Equipment Market size was valued at USD 2.6 Billion in 2024 and is poised to grow from USD 2.8 Billion in 2025 to USD 5.03 Billion by 2033, growing at a CAGR of 7.6% during the forecast period (2026-2033).

The nuclear medicine equipment market is expanding due to a pivotal transition towards molecular imaging and precision diagnostics, facilitating early detection and targeted therapies that enhance patient outcomes. This equipment encompasses gamma cameras, SPECT, PET, PET/CT, and PET/MRI hybrid scanners, alongside cyclotrons and radiopharmacy tools, translating radiopharmaceutical science into actionable clinical decisions. The adoption of these technologies has surged, particularly in oncology and cardiology, as facilities utilize PET imaging for cancer staging, significantly altering prostate cancer management with PSMA PET. Furthermore, the burgeoning ecosystem of radiopharmaceuticals drives global demand, with reliable isotope supply encouraging scanner usage. Enhanced reimbursement rates, along with advancements in AI and image analysis, are prompting hospitals to invest in hybrid systems and expand services, particularly in emerging markets.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nuclear Medicine Equipment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nuclear Medicine Equipment Market Segments Analysis

Global nuclear medicine equipment market is segmented by product type, application, end-user and region. Based on product type, the market is segmented into SPECT Systems, PET Systems, Planar Scintigraphy and Others. Based on application, the market is segmented into Oncology, Cardiology, Neurology and Others. Based on end-user, the market is segmented into Hospitals, Diagnostic Centers and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Nuclear Medicine Equipment Market

The increasing prevalence of cancer and cardiovascular diseases has significantly heightened the demand for innovative diagnostic and therapeutic solutions within the global nuclear medicine sector. Nuclear medicine offers distinct molecular and functional insights that aid in personalizing treatment strategies. As healthcare professionals increasingly depend on nuclear imaging and radiopharmaceutical therapies for early disease detection, treatment monitoring, and customized patient interventions, hospitals and imaging facilities are motivated to enhance their investments in advanced infrastructure such as PET, SPECT, and radionuclide therapy. This clinical urgency fuels the procurement and development of cutting-edge equipment throughout healthcare systems, shaping the landscape of nuclear medicine.

Restraints in the Global Nuclear Medicine Equipment Market

The Global Nuclear Medicine Equipment market faces significant restraints due to the high capital expenditures associated with acquiring and maintaining advanced technology. Financial barriers arise from not only the initial purchase costs but also the necessary modifications to facilities and the ongoing maintenance required for specialized equipment. This operational complexity, combined with the need for regular servicing and access to radiopharmacy resources, adds to the fiscal strain. As a result, smaller healthcare providers and facilities in resource-constrained environments may hesitate to invest or may opt to focus on other diagnostic methods, ultimately hindering the market's growth and slowing the adoption of innovative technologies despite their clinical advantages and demand.

Market Trends of the Global Nuclear Medicine Equipment Market

The Global Nuclear Medicine Equipment market is witnessing a significant trend towards the integration and expansion of theranostics, which combines diagnostic imaging with targeted radionuclide therapy. This evolving landscape demands that equipment manufacturers innovate their designs for imaging agents, detectors, and delivery systems to support dual diagnostic-therapeutic workflows. Key stakeholders, including manufacturers, clinical centers, and research institutions, are prioritizing modular designs and cross-disciplinary protocols to foster personalized treatment planning. As collaborative ecosystems emerge, the demand for flexible platforms that facilitate patient-centric care models is increasing, thereby enhancing clinical decision-making and operational coordination across multiple sites within a unified clinical environment.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Nuclear Medicine Equipment Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• SPECT Systems
  • Hybrid SPECT Systems
  • Standalone SPECT Systems
• PET Systems
• Planar Scintigraphy
• Others

Global Nuclear Medicine Equipment Market Size by Application & CAGR (2026-2033)

• Market Overview
• Oncology
• Cardiology
• Neurology
• Others

Global Nuclear Medicine Equipment Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Centers
• Research Institutes

Global Nuclear Medicine Equipment Market Size & CAGR (2026-2033)

• North America (Product Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Siemens Energy
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• General Electric
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digirad
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mediso Medical Imaging Systems
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Surgeons Choice Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eckert & Ziegler
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cardinal Health
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bracco
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Spectrum Dynamics Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CMR Naviscan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Milaidhoo
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Segami Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedEx
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nuclisys
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations